{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T04:05:59Z","timestamp":1792037159921,"version":"4.4.0"},"reference-count":129,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,4,26]],"date-time":"2025-04-26T00:00:00Z","timestamp":1745625600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,26]],"date-time":"2025-04-26T00:00:00Z","timestamp":1745625600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Science and Technology Development Fund, Macau SAR","award":["0023\/2024\/ITP1"],"award-info":[{"award-number":["0023\/2024\/ITP1"]}]},{"name":"Science and Technology Development Fund, Macau SAR","award":["0098\/2021\/A2 and 0048\/2023\/AFJ"],"award-info":[{"award-number":["0098\/2021\/A2 and 0048\/2023\/AFJ"]}]},{"name":"Chinese Medicine Guangdong Laboratory","award":["HQCML-C-2024006"],"award-info":[{"award-number":["HQCML-C-2024006"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Oncol Rep"],"DOI":"10.1007\/s11912-025-01677-z","type":"journal-article","created":{"date-parts":[[2025,4,26]],"date-time":"2025-04-26T00:48:22Z","timestamp":1745628502000},"page":"703-716","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Linking Hyperuricemia to Cancer: Emerging Evidence on Risk and Progression"],"prefix":"10.1007","volume":"27","author":[{"given":"Lingyun","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruihong","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziming","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhonghan","family":"Lou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianfeng","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiu Yee","family":"Kwan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qibiao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keyang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,26]]},"reference":[{"key":"1677_CR1","doi-asserted-by":"publisher","first-page":"155999","DOI":"10.1016\/j.metabol.2024.155999","volume":"160","author":"H Zhang","year":"2024","unstructured":"Zhang H, et al. Global burden of metabolic diseases, 1990\u20132021. Metabolism. 2024;160:155999.","journal-title":"Metabolism"},{"issue":"5","key":"1677_CR2","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1038\/s41590-021-00886-5","volume":"22","author":"BR Sharma","year":"2021","unstructured":"Sharma BR, Kanneganti T-D. NLRP3 inflammasome in cancer and metabolic diseases. Nat Immunol. 2021;22(5):550\u20139.","journal-title":"Nat Immunol"},{"issue":"1","key":"1677_CR3","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1038\/s41392-024-01916-y","volume":"9","author":"L Du","year":"2024","unstructured":"Du L, et al. Hyperuricemia and its related diseases: mechanisms and advances in therapy. Signal Transduct Target Ther. 2024;9(1):212.","journal-title":"Signal Transduct Target Ther"},{"issue":"6","key":"1677_CR4","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1002\/lipd.12411","volume":"59","author":"J Yang","year":"2024","unstructured":"Yang J, et al. The predictive value of TyG and lipid ratios on the development of complications and hyperuricemia in patients with type 2 diabetes mellitus. Lipids. 2024;59(6):209\u201319.","journal-title":"Lipids"},{"issue":"19","key":"1677_CR5","doi-asserted-by":"publisher","first-page":"4959","DOI":"10.3390\/cancers14194959","volume":"14","author":"S Allegrini","year":"2022","unstructured":"Allegrini S, et al. The good, the bad and the new about uric acid in cancer. Cancers. 2022;14(19):4959.","journal-title":"Cancers"},{"issue":"4","key":"1677_CR6","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1097\/CEJ.0000000000000440","volume":"27","author":"F Dovell","year":"2018","unstructured":"Dovell F, Boffetta P. Serum uric acid and cancer mortality and incidence: a systematic review and meta-analysis. Eur J Cancer Prev. 2018;27(4):399\u2013405.","journal-title":"Eur J Cancer Prev"},{"issue":"5","key":"1677_CR7","doi-asserted-by":"publisher","first-page":"E827","DOI":"10.1152\/ajpendo.00378.2020","volume":"319","author":"M Furuhashi","year":"2020","unstructured":"Furuhashi M. New insights into purine metabolism in metabolic diseases: role of xanthine oxidoreductase activity. Am J Physiol Endocrinol Metab. 2020;319(5):E827-e834.","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"8","key":"1677_CR8","doi-asserted-by":"publisher","first-page":"7027","DOI":"10.3390\/ijms24087027","volume":"24","author":"AFG Cicero","year":"2023","unstructured":"Cicero AFG, et al. Purine metabolism dysfunctions: Experimental methods of detection and diagnostic potential. Int J Mol Sci. 2023;24(8):7027.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"1677_CR9","first-page":"167","volume":"73","author":"MJ Kim","year":"2016","unstructured":"Kim MJ, Mayr M. Uric acid and kidneys \u2013 Physiological and pathophysiological aspects. Therapeutische Umschau. Revue Ther. 2016;73(3):167\u201375.","journal-title":"Revue Ther"},{"issue":"6","key":"1677_CR10","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1007\/s00467-013-2549-x","volume":"29","author":"SA Fathallah-Shaykh","year":"2014","unstructured":"Fathallah-Shaykh SA, Cramer MT. Uric acid and the kidney. Pediatr Nephrol. 2014;29(6):999\u20131008.","journal-title":"Pediatr Nephrol"},{"issue":"11","key":"1677_CR11","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1038\/s41422-024-01023-1","volume":"34","author":"Y Dai","year":"2024","unstructured":"Dai Y, Lee C-H. Transport mechanism and structural pharmacology of human urate transporter URAT1. Cell Res. 2024;34(11):776\u201387.","journal-title":"Cell Res"},{"key":"1677_CR12","doi-asserted-by":"publisher","first-page":"174291","DOI":"10.1016\/j.ejphar.2021.174291","volume":"907","author":"D Song","year":"2021","unstructured":"Song D, et al. A brief review of urate transporter 1 (URAT1) inhibitors for the treatment of hyperuricemia and gout: Current therapeutic options and potential applications. Eur J Pharmacol. 2021;907:174291.","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"1677_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5049\/EBP.2021.19.1.1","volume":"19","author":"S Chung","year":"2021","unstructured":"Chung S, Kim GH. Urate transporters in the kidney: What clinicians need to know. Electrolyte Blood Press. 2021;19(1):1\u20139.","journal-title":"Electrolyte Blood Press"},{"issue":"26","key":"1677_CR14","doi-asserted-by":"publisher","first-page":"42332","DOI":"10.18632\/oncotarget.16198","volume":"8","author":"A Yiu","year":"2017","unstructured":"Yiu A, et al. Circulating uric acid levels and subsequent development of cancer in 493,281 individuals: findings from the AMORIS Study. Oncotarget. 2017;8(26):42332\u201342.","journal-title":"Oncotarget"},{"issue":"11","key":"1677_CR15","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1136\/thoraxjnl-2014-205271","volume":"69","author":"LJ Horsfall","year":"2014","unstructured":"Horsfall LJ, Nazareth I, Petersen I. Serum uric acid and the risk of respiratory disease: a population-based cohort study. Thorax. 2014;69(11):1021\u20136.","journal-title":"Thorax"},{"issue":"1","key":"1677_CR16","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.annepidem.2008.08.009","volume":"19","author":"AM Strasak","year":"2009","unstructured":"Strasak AM, et al. Use of penalized splines in extended Cox-type additive hazard regression to flexibly estimate the effect of time-varying serum uric acid on risk of cancer incidence: a prospective, population-based study in 78,850 men. Ann Epidemiol. 2009;19(1):15\u201324.","journal-title":"Ann Epidemiol"},{"issue":"2","key":"1677_CR17","first-page":"242","volume":"71","author":"E Benli","year":"2018","unstructured":"Benli E, et al. Comparison of serum uric acid levels between prostate cancer patients and a control group. Cent European J Urol. 2018;71(2):242\u20137.","journal-title":"Cent European J Urol"},{"issue":"3","key":"1677_CR18","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1002\/dmrr.2724","volume":"32","author":"Z Deng","year":"2016","unstructured":"Deng Z, et al. Association between uric acid, cancer incidence and mortality in patients with type 2 diabetes: Shanghai diabetes registry study. Diabetes Metab Res Rev. 2016;32(3):325\u201332.","journal-title":"Diabetes Metab Res Rev"},{"issue":"1","key":"1677_CR19","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1002\/ijc.30731","volume":"141","author":"J Yang","year":"2017","unstructured":"Yang J, et al. Association of serum uric acid with increased risk of cancer among hypertensive Chinese. Int J Cancer. 2017;141(1):112\u201320.","journal-title":"Int J Cancer"},{"issue":"7","key":"1677_CR20","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1158\/1055-9965.EPI-19-0161","volume":"28","author":"A Wang","year":"2019","unstructured":"Wang A, et al. Serum urate, genetic variation, and prostate cancer risk: Atherosclerosis risk in communities (ARIC) study. Cancer Epidemiol Biomarkers Prev. 2019;28(7):1259\u201361.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"1","key":"1677_CR21","first-page":"9","volume":"10","author":"AO Lawal","year":"2012","unstructured":"Lawal AO, Kolude B, Adeyemi BF. Serum uric Acid levels in oral cancer patients seen at tertiary institution in Nigeria. Ann Ib Postgrad Med. 2012;10(1):9\u201312.","journal-title":"Ann Ib Postgrad Med"},{"issue":"10","key":"1677_CR22","first-page":"2916","volume":"48","author":"RA Hiatt","year":"1988","unstructured":"Hiatt RA, Fireman BH. Serum uric acid unrelated to cancer incidence in humans. Cancer Res. 1988;48(10):2916\u20138.","journal-title":"Cancer Res"},{"issue":"6","key":"1677_CR23","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1373\/clinchem.2016.268185","volume":"63","author":"CJ Kobylecki","year":"2017","unstructured":"Kobylecki CJ, Afzal S, Nordestgaard BG. Plasma urate, cancer incidence, and all-cause mortality: A Mendelian randomization study. Clin Chem. 2017;63(6):1151\u201360.","journal-title":"Clin Chem"},{"issue":"3","key":"1677_CR24","first-page":"225","volume":"3","author":"LN Kolonel","year":"1994","unstructured":"Kolonel LN, et al. Relationship of serum uric acid to cancer occurrence in a prospective male cohort. Cancer Epidemiol Biomarkers Prev. 1994;3(3):225\u20138.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"2","key":"1677_CR25","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1097\/CEJ.0b013e328313631a","volume":"18","author":"P Boffetta","year":"2009","unstructured":"Boffetta P, et al. A prospective study of gout and cancer. Eur J Cancer Prev. 2009;18(2):127\u201332.","journal-title":"Eur J Cancer Prev"},{"issue":"3","key":"1677_CR26","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1097\/CEJ.0000000000000161","volume":"25","author":"CJ Chen","year":"2016","unstructured":"Chen CJ, et al. Allopurinol and the incidence of bladder cancer: a Taiwan national retrospective cohort study. Eur J Cancer Prev. 2016;25(3):216\u201323.","journal-title":"Eur J Cancer Prev"},{"issue":"1","key":"1677_CR27","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1093\/rheumatology\/kes223","volume":"52","author":"CF Kuo","year":"2013","unstructured":"Kuo CF, et al. Significance of serum uric acid levels on the risk of all-cause and cardiovascular mortality. Rheumatology (Oxford). 2013;52(1):127\u201334.","journal-title":"Rheumatology (Oxford)"},{"issue":"10","key":"1677_CR28","doi-asserted-by":"publisher","first-page":"e028892","DOI":"10.1136\/bmjopen-2019-028892","volume":"9","author":"JP Chuang","year":"2019","unstructured":"Chuang JP, et al. Association of gout and colorectal cancer in Taiwan: a nationwide population-based cohort study. BMJ Open. 2019;9(10):e028892.","journal-title":"BMJ Open"},{"issue":"2","key":"1677_CR29","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1002\/ijc.33807","volume":"150","author":"N Mi","year":"2022","unstructured":"Mi N, et al. High serum uric acid may associate with the increased risk of colorectal cancer in females: A prospective cohort study. Int J Cancer. 2022;150(2):263\u201372.","journal-title":"Int J Cancer"},{"issue":"44","key":"1677_CR30","doi-asserted-by":"publisher","first-page":"7061","DOI":"10.3748\/wjg.v26.i44.7061","volume":"26","author":"CF Huang","year":"2020","unstructured":"Huang CF, et al. Associations between serum uric acid and hepatobiliary-pancreatic cancer: A cohort study. World J Gastroenterol. 2020;26(44):7061\u201375.","journal-title":"World J Gastroenterol"},{"issue":"15","key":"1677_CR31","doi-asserted-by":"publisher","first-page":"5655","DOI":"10.1002\/cam4.3214","volume":"9","author":"XY Dai","year":"2020","unstructured":"Dai XY, et al. Serum uric acid levels and risk of kidney cancer incidence and mortality: A prospective cohort study. Cancer Med. 2020;9(15):5655\u201361.","journal-title":"Cancer Med"},{"issue":"3","key":"1677_CR32","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1007\/s00394-022-03076-7","volume":"62","author":"Y Deng","year":"2023","unstructured":"Deng Y, Huang J, Wong MCS. Association between serum uric acid and prostate cancer risk in East Asian populations: a Mendelian randomization study. Eur J Nutr. 2023;62(3):1323\u20139.","journal-title":"Eur J Nutr"},{"issue":"10","key":"1677_CR33","doi-asserted-by":"publisher","first-page":"7629","DOI":"10.1007\/s00432-023-04725-y","volume":"149","author":"K Fan","year":"2023","unstructured":"Fan K, Sun T, Yin F. J-shaped association between uric acid and breast cancer risk: a prospective case-control study. J Cancer Res Clin Oncol. 2023;149(10):7629\u201336.","journal-title":"J Cancer Res Clin Oncol"},{"key":"1677_CR34","doi-asserted-by":"publisher","first-page":"742411","DOI":"10.3389\/fendo.2021.742411","volume":"12","author":"Y Feng","year":"2021","unstructured":"Feng Y, et al. Uric acid mediated the association between BMI and postmenopausal breast cancer incidence: A bidirectional mendelian randomization analysis and prospective cohort study. Front Endocrinol (Lausanne). 2021;12:742411.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"1677_CR35","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1186\/s12885-024-12576-0","volume":"24","author":"P Lin","year":"2024","unstructured":"Lin P, et al. Exploring the causal association between uric acid and lung cancer in east Asian and European populations: a mendelian randomization study. BMC Cancer. 2024;24(1):801.","journal-title":"BMC Cancer"},{"issue":"9","key":"1677_CR36","doi-asserted-by":"publisher","first-page":"792","DOI":"10.3349\/ymj.2021.62.9.792","volume":"62","author":"YR Kim","year":"2021","unstructured":"Kim YR, et al. Association between Albumin, Total Bilirubin, and Uric Acid Serum Levels and the Risk of Cancer: A Prospective Study in a Korean Population. Yonsei Med J. 2021;62(9):792\u20138.","journal-title":"Yonsei Med J"},{"key":"1677_CR37","doi-asserted-by":"publisher","first-page":"764250","DOI":"10.1155\/2015\/764250","volume":"2015","author":"S Yan","year":"2015","unstructured":"Yan S, et al. Serum Uric Acid Increases Risk of Cancer Incidence and Mortality: A Systematic Review and Meta-Analysis. Mediators Inflamm. 2015;2015:764250.","journal-title":"Mediators Inflamm"},{"issue":"3","key":"1677_CR38","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1515\/cclm-2014-0486","volume":"53","author":"J Szkandera","year":"2015","unstructured":"Szkandera J, et al. Uric acid levels in blood are associated with clinical outcome in soft-tissue sarcoma patients. Clin Chem Lab Med. 2015;53(3):493\u20137.","journal-title":"Clin Chem Lab Med"},{"issue":"10","key":"1677_CR39","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1038\/bjc.2017.313","volume":"117","author":"T Kuhn","year":"2017","unstructured":"Kuhn T, et al. Albumin, bilirubin, uric acid and cancer risk: results from a prospective population-based study. Br J Cancer. 2017;117(10):1572\u20139.","journal-title":"Br J Cancer"},{"issue":"9","key":"1677_CR40","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1007\/s10552-007-9043-3","volume":"18","author":"AM Strasak","year":"2007","unstructured":"Strasak AM, et al. Serum uric acid and risk of cancer mortality in a large prospective male cohort. Cancer Causes Control. 2007;18(9):1021\u20139.","journal-title":"Cancer Causes Control"},{"issue":"8","key":"1677_CR41","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1007\/s10552-014-0408-0","volume":"25","author":"N Taghizadeh","year":"2014","unstructured":"Taghizadeh N, Vonk JM, Boezen HM. Serum uric acid levels and cancer mortality risk among males in a large general population-based cohort study. Cancer Causes Control. 2014;25(8):1075\u201380.","journal-title":"Cancer Causes Control"},{"issue":"11","key":"1677_CR42","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1093\/annonc\/mdm338","volume":"18","author":"AM Strasak","year":"2007","unstructured":"Strasak AM, et al. The role of serum uric acid as an antioxidant protecting against cancer: prospective study in more than 28 000 older Austrian women. Ann Oncol. 2007;18(11):1893\u20137.","journal-title":"Ann Oncol"},{"issue":"19","key":"1677_CR43","doi-asserted-by":"publisher","first-page":"2552","DOI":"10.1001\/jama.283.19.2552","volume":"283","author":"SM Gapstur","year":"2000","unstructured":"Gapstur SM, et al. Abnormal glucose metabolism and pancreatic cancer mortality. JAMA. 2000;283(19):2552\u20138.","journal-title":"JAMA"},{"issue":"3","key":"1677_CR44","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1097\/01.hjr.0000130222.50258.22","volume":"11","author":"SH Jee","year":"2004","unstructured":"Jee SH, Lee SY, Kim MT. Serum uric acid and risk of death from cancer, cardiovascular disease or all causes in men. Eur J Cardiovasc Prevent Rehab. 2004;11(3):185\u201391.","journal-title":"Eur J Cardiovasc Prevent Rehab"},{"issue":"2","key":"1677_CR45","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/j.atherosclerosis.2014.01.026","volume":"233","author":"SP Juraschek","year":"2014","unstructured":"Juraschek SP, Tunstall-Pedoe H, Woodward M. Serum uric acid and the risk of mortality during 23 years follow-up in the Scottish Heart Health Extended Cohort Study. Atherosclerosis. 2014;233(2):623\u20139.","journal-title":"Atherosclerosis"},{"issue":"3","key":"1677_CR46","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/0895-4356(89)90061-9","volume":"42","author":"W Levine","year":"1989","unstructured":"Levine W, et al. Serum uric acid and 11.5-year mortality of middle-aged women: findings of the Chicago Heart Association Detection Project in Industry. J Clin Epidemiol. 1989;42(3):257\u201367.","journal-title":"J Clin Epidemiol"},{"issue":"6","key":"1677_CR47","doi-asserted-by":"publisher","first-page":"403","DOI":"10.2188\/jea.10.403","volume":"10","author":"M Tomita","year":"2000","unstructured":"Tomita M, et al. Does hyperuricemia affect mortality? A prospective cohort study of Japanese male workers. J Epidemiol. 2000;10(6):403\u20139.","journal-title":"J Epidemiol"},{"issue":"9","key":"1677_CR48","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1111\/jgs.13607","volume":"63","author":"CY Wu","year":"2015","unstructured":"Wu CY, et al. High serum uric acid levels are associated with all-cause and cardiovascular, but not cancer, mortality in elderly adults. J Am Geriatr Soc. 2015;63(9):1829\u201336.","journal-title":"J Am Geriatr Soc"},{"issue":"5","key":"1677_CR49","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1023\/A:1007543725207","volume":"15","author":"A Mazza","year":"1999","unstructured":"Mazza A, et al. Predictors of cancer mortality in elderly subjects. Eur J Epidemiol. 1999;15(5):421\u20137.","journal-title":"Eur J Epidemiol"},{"key":"1677_CR50","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.cca.2017.08.027","volume":"473","author":"CF Yue","year":"2017","unstructured":"Yue CF, et al. High serum uric acid concentration predicts poor survival in patients with breast cancer. Clin Chim Acta. 2017;473:160\u20135.","journal-title":"Clin Chim Acta"},{"issue":"1","key":"1677_CR51","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s13075-020-02173-4","volume":"22","author":"S Li","year":"2020","unstructured":"Li S, et al. Repeated measurements of serum urate and mortality: a prospective cohort study of 152,358 individuals over 8 years of follow-up. Arthritis Res Ther. 2020;22(1):84.","journal-title":"Arthritis Res Ther"},{"issue":"4","key":"1677_CR52","doi-asserted-by":"publisher","first-page":"536","DOI":"10.3390\/cancers11040536","volume":"11","author":"K Yim","year":"2019","unstructured":"Yim K, et al. Rising serum uric acid level is negatively associated with survival in renal cell carcinoma. Cancers (Basel). 2019;11(4):536.","journal-title":"Cancers (Basel)"},{"issue":"7","key":"1677_CR53","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.3324\/haematol.2019.228668","volume":"105","author":"O Penack","year":"2020","unstructured":"Penack O, et al. Association of uric acid levels before start of conditioning with mortality after allogeneic hematopoietic stem cell transplantation - a prospective, non-interventional study of the EBMT Transplant Complication Working Party. Haematologica. 2020;105(7):1977\u201383.","journal-title":"Haematologica"},{"issue":"17","key":"1677_CR54","doi-asserted-by":"publisher","first-page":"2073","DOI":"10.1097\/CM9.0000000000001631","volume":"134","author":"DY Chang","year":"2021","unstructured":"Chang DY, et al. Association between serum uric acid level and mortality in China. Chin Med J (Engl). 2021;134(17):2073\u201380.","journal-title":"Chin Med J (Engl)"},{"issue":"1","key":"1677_CR55","doi-asserted-by":"publisher","first-page":"e597","DOI":"10.1210\/clinem\/dgz068","volume":"105","author":"L Hu","year":"2020","unstructured":"Hu L, et al. U-shaped association of serum uric acid with all-cause and cause-specific mortality in us adults: A cohort study. J Clin Endocrinol Metab. 2020;105(1):e597\u2013609.","journal-title":"J Clin Endocrinol Metab"},{"issue":"16","key":"1677_CR56","doi-asserted-by":"publisher","first-page":"17056","DOI":"10.1002\/cam4.6344","volume":"12","author":"YHA Lee","year":"2023","unstructured":"Lee YHA, et al. Association between serum uric acid and prostate cancer mortality in androgen deprivation therapy: A population-based cohort study. Cancer Med. 2023;12(16):17056\u201360.","journal-title":"Cancer Med"},{"issue":"2","key":"1677_CR57","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1111\/j.1742-481X.2011.00870.x","volume":"9","author":"ML Fernandez","year":"2012","unstructured":"Fernandez ML, et al. Elevated uric acid correlates with wound severity. Int Wound J. 2012;9(2):139\u201349.","journal-title":"Int Wound J"},{"issue":"4","key":"1677_CR58","doi-asserted-by":"publisher","first-page":"e10044","DOI":"10.1371\/journal.pone.0010044","volume":"5","author":"S Chigurupati","year":"2010","unstructured":"Chigurupati S, et al. A synthetic uric acid analog accelerates cutaneous wound healing in mice. PLoS ONE. 2010;5(4):e10044.","journal-title":"PLoS ONE"},{"issue":"10","key":"1677_CR59","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/s12032-014-0217-z","volume":"31","author":"O Tanriverdi","year":"2014","unstructured":"Tanriverdi O, et al. Prognostic significance of the baseline serum uric acid level in non-small cell lung cancer patients treated with first-line chemotherapy: a study of the Turkish descriptive oncological researches group. Med Oncol. 2014;31(10):217.","journal-title":"Med Oncol"},{"issue":"1","key":"1677_CR60","doi-asserted-by":"publisher","first-page":"89","DOI":"10.3233\/CBM-160621","volume":"17","author":"YF Chen","year":"2016","unstructured":"Chen YF, et al. Prognostic value of pre-operative serum uric acid levels in esophageal squamous cell carcinoma patients who undergo R0 esophagectomy. Cancer Biomark. 2016;17(1):89\u201396.","journal-title":"Cancer Biomark"},{"key":"1677_CR61","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1186\/1748-717X-8-121","volume":"8","author":"H Lin","year":"2013","unstructured":"Lin H, et al. Plasma uric acid and tumor volume are highly predictive of outcome in nasopharyngeal carcinoma patients receiving intensity modulated radiotherapy. Radiat Oncol. 2013;8:121.","journal-title":"Radiat Oncol"},{"issue":"3","key":"1677_CR62","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1002\/hed.24631","volume":"39","author":"XJ Du","year":"2017","unstructured":"Du XJ, et al. Use of pretreatment serum uric acid level to predict metastasis in locally advanced nasopharyngeal carcinoma. Head Neck. 2017;39(3):492\u20137.","journal-title":"Head Neck"},{"issue":"9","key":"1677_CR63","first-page":"3947","volume":"33","author":"T Yamauchi","year":"2013","unstructured":"Yamauchi T, et al. A high serum uric acid level is associated with poor prognosis in patients with acute myeloid leukemia. Anticancer Res. 2013;33(9):3947\u201351.","journal-title":"Anticancer Res"},{"issue":"2","key":"1677_CR64","first-page":"485","volume":"18","author":"AO Cetin","year":"2017","unstructured":"Cetin AO, et al. Hyperuricemia at The Time Of Diagnosis is a Factor for Poor Prognosis in Patients With Stage II and III Colorectal Cancer (Uric Acid and Colorectal Cancer). Asian Pac J Cancer Prev. 2017;18(2):485\u201390.","journal-title":"Asian Pac J Cancer Prev"},{"key":"1677_CR65","doi-asserted-by":"publisher","first-page":"5895","DOI":"10.2147\/OTT.S175112","volume":"11","author":"L Mao","year":"2018","unstructured":"Mao L, Guo C, Zheng S. Elevated urinary 8-oxo-7,8-dihydro-2\u2019-deoxyguanosine and serum uric acid are associated with progression and are prognostic factors of colorectal cancer. Onco Targets Ther. 2018;11:5895\u2013902.","journal-title":"Onco Targets Ther"},{"key":"1677_CR66","doi-asserted-by":"publisher","first-page":"1821969","DOI":"10.1155\/2019\/1821969","volume":"2019","author":"CY Hsueh","year":"2019","unstructured":"Hsueh CY, et al. Pretreatment serum uric acid as an efficient predictor of prognosis in men with laryngeal squamous cell cancer: a retrospective cohort study. Oxid Med Cell Longev. 2019;2019:1821969.","journal-title":"Oxid Med Cell Longev"},{"key":"1677_CR67","doi-asserted-by":"publisher","first-page":"1415421","DOI":"10.1155\/2019\/1415421","volume":"2019","author":"S Yang","year":"2019","unstructured":"Yang S, et al. Prognostic significance of serum uric acid and gamma-glutamyltransferase in patients with advanced gastric cancer. Dis Markers. 2019;2019:1415421.","journal-title":"Dis Markers"},{"issue":"2","key":"1677_CR68","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1002\/ijc.28374","volume":"134","author":"T Dziaman","year":"2014","unstructured":"Dziaman T, et al. 8-Oxo-7,8-dihydroguanine and uric acid as efficient predictors of survival in colon cancer patients. Int J Cancer. 2014;134(2):376\u201383.","journal-title":"Int J Cancer"},{"issue":"6","key":"1677_CR69","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1080\/01635581.2020.1779758","volume":"73","author":"M Hayashi","year":"2021","unstructured":"Hayashi M, et al. High serum uric acid levels could be a risk factor of hepatocellular carcinoma recurrences. Nutr Cancer. 2021;73(6):996\u20131003.","journal-title":"Nutr Cancer"},{"issue":"8","key":"1677_CR70","doi-asserted-by":"publisher","first-page":"e104730","DOI":"10.1371\/journal.pone.0104730","volume":"9","author":"M Stotz","year":"2014","unstructured":"Stotz M, et al. Evaluation of uric acid as a prognostic blood-based marker in a large cohort of pancreatic cancer patients. PLoS ONE. 2014;9(8):e104730.","journal-title":"PLoS ONE"},{"issue":"1","key":"1677_CR71","doi-asserted-by":"publisher","first-page":"73","DOI":"10.3892\/ol.2020.12334","volume":"21","author":"H Wang","year":"2021","unstructured":"Wang H, et al. Correlation analysis of serum cystatin C, uric acid and lactate dehydrogenase levels before chemotherapy on the prognosis of small-cell lung cancer. Oncol Lett. 2021;21(1):73.","journal-title":"Oncol Lett"},{"issue":"1","key":"1677_CR72","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1186\/s12885-021-08285-7","volume":"21","author":"Y Xu","year":"2021","unstructured":"Xu Y, et al. Prognostic value of serum uric acid and tumor response to induction chemotherapy in locally advanced nasopharyngeal carcinoma. BMC Cancer. 2021;21(1):519.","journal-title":"BMC Cancer"},{"key":"1677_CR73","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.clnesp.2020.03.017","volume":"37","author":"DB Trindade","year":"2020","unstructured":"Trindade DB, et al. Serum uric acid concentration is not associated with handgrip strength, lean body mass or survival in gastrointestinal cancer patients. Clin Nutr ESPEN. 2020;37:75\u20139.","journal-title":"Clin Nutr ESPEN"},{"issue":"2","key":"1677_CR74","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1038\/s12276-020-0384-2","volume":"52","author":"B Perillo","year":"2020","unstructured":"Perillo B, et al. ROS in cancer therapy: the bright side of the moon. Exp Mol Med. 2020;52(2):192\u2013203.","journal-title":"Exp Mol Med"},{"issue":"10","key":"1677_CR75","doi-asserted-by":"publisher","first-page":"3945","DOI":"10.1111\/cas.15068","volume":"112","author":"H Nakamura","year":"2021","unstructured":"Nakamura H, Takada K. Reactive oxygen species in cancer: Current findings and future directions. Cancer Sci. 2021;112(10):3945\u201352.","journal-title":"Cancer Sci"},{"issue":"6","key":"1677_CR76","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1080\/15257770802138558","volume":"27","author":"YY Sautin","year":"2008","unstructured":"Sautin YY, Johnson RJ. Uric acid: the oxidant-antioxidant paradox. Nucleosides Nucleotides Nucleic Acids. 2008;27(6):608\u201319.","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"key":"1677_CR77","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.neurobiolaging.2018.10.031","volume":"75","author":"RG Cutler","year":"2019","unstructured":"Cutler RG, et al. Uric acid enhances longevity and endurance and protects the brain against ischemia. Neurobiol Aging. 2019;75:159\u201368.","journal-title":"Neurobiol Aging"},{"key":"1677_CR78","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.canlet.2016.03.042","volume":"387","author":"S Prasad","year":"2017","unstructured":"Prasad S, Gupta SC, Tyagi AK. Reactive oxygen species (ROS) and cancer: Role of antioxidative nutraceuticals. Cancer Lett. 2017;387:95\u2013105.","journal-title":"Cancer Lett"},{"key":"1677_CR79","doi-asserted-by":"publisher","first-page":"1282890","DOI":"10.3389\/fimmu.2023.1282890","volume":"14","author":"D Li","year":"2023","unstructured":"Li D, et al. The dysregulation of immune cells induced by uric acid: mechanisms of inflammation associated with hyperuricemia and its complications. Front Immunol. 2023;14:1282890.","journal-title":"Front Immunol"},{"issue":"3","key":"1677_CR80","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1002\/mc.23664","volume":"63","author":"H Chen","year":"2024","unstructured":"Chen H, et al. Can uric acid affect the immune microenvironment in bladder cancer? A single-center multi-omics study. Mol Carcinog. 2024;63(3):461\u201378.","journal-title":"Mol Carcinog"},{"issue":"11","key":"1677_CR81","doi-asserted-by":"publisher","first-page":"5842","DOI":"10.4049\/jimmunol.1101408","volume":"187","author":"C Conforti-Andreoni","year":"2011","unstructured":"Conforti-Andreoni C, et al. Uric acid-driven Th17 differentiation requires inflammasome-derived IL-1 and IL-18. J Immunol (Baltimore, Md 1950). 2011;187(11):5842\u201350.","journal-title":"J Immunol (Baltimore, Md 1950)"},{"issue":"6957","key":"1677_CR82","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1038\/nature01991","volume":"425","author":"Y Shi","year":"2003","unstructured":"Shi Y, Evans JE, Rock KL. Molecular identification of a danger signal that alerts the immune system to dying cells. Nature. 2003;425(6957):516\u201321.","journal-title":"Nature"},{"issue":"4","key":"1677_CR83","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/j.immuni.2011.03.015","volume":"34","author":"M Kool","year":"2011","unstructured":"Kool M, et al. An unexpected role for uric acid as an inducer of T helper 2 cell immunity to inhaled antigens and inflammatory mediator of allergic asthma. Immunity. 2011;34(4):527\u201340.","journal-title":"Immunity"},{"issue":"4","key":"1677_CR84","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1056\/NEJMcibr032455","volume":"350","author":"KR Jerome","year":"2004","unstructured":"Jerome KR, Corey L. The danger within. N Engl J Med. 2004;350(4):411\u20132.","journal-title":"N Engl J Med"},{"issue":"15","key":"1677_CR85","doi-asserted-by":"publisher","first-page":"5059","DOI":"10.1158\/0008-5472.CAN-04-1586","volume":"64","author":"D-E Hu","year":"2004","unstructured":"Hu D-E, et al. Uric acid promotes tumor immune rejection. Can Res. 2004;64(15):5059\u201362.","journal-title":"Can Res"},{"issue":"26","key":"1677_CR86","doi-asserted-by":"publisher","first-page":"14590","DOI":"10.1073\/pnas.260497597","volume":"97","author":"Y Shi","year":"2000","unstructured":"Shi Y, Zheng W, Rock KL. Cell injury releases endogenous adjuvants that stimulate cytotoxic T cell responses. Proc Natl Acad Sci U S A. 2000;97(26):14590\u20135.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"114","key":"1677_CR87","first-page":"135","volume":"21","author":"BA Hanks","year":"2016","unstructured":"Hanks BA. Immune evasion pathways and the design of dendritic cell-based cancer vaccines. Discov Med. 2016;21(114):135\u201342.","journal-title":"Discov Med"},{"key":"1677_CR88","doi-asserted-by":"publisher","first-page":"16427","DOI":"10.1038\/srep16427","volume":"5","author":"Y Wang","year":"2015","unstructured":"Wang Y, et al. Uric acid enhances the antitumor immunity of dendritic cell-based vaccine. Sci Rep. 2015;5:16427.","journal-title":"Sci Rep"},{"issue":"7","key":"1677_CR89","doi-asserted-by":"publisher","first-page":"3905","DOI":"10.4049\/jimmunol.176.7.3905","volume":"176","author":"Y Shi","year":"2006","unstructured":"Shi Y, Galusha SA, Rock KL. Cutting edge: elimination of an endogenous adjuvant reduces the activation of CD8 T lymphocytes to transplanted cells and in an autoimmune diabetes model. J Immunol. 2006;176(7):3905\u20138.","journal-title":"J Immunol"},{"issue":"16","key":"1677_CR90","doi-asserted-by":"publisher","first-page":"4711","DOI":"10.3390\/molecules26164711","volume":"26","author":"S Hao","year":"2021","unstructured":"Hao S, et al. Insulin receptor substrate 1 is involved in the phycocyanin-mediated antineoplastic function of non-small cell lung cancer cells. Molecules. 2021;26(16):4711.","journal-title":"Molecules"},{"issue":"22","key":"1677_CR91","doi-asserted-by":"publisher","first-page":"9197","DOI":"10.1158\/0008-5472.CAN-10-1568","volume":"70","author":"Y Tan","year":"2010","unstructured":"Tan Y, et al. Upregulation of DLX5 promotes ovarian cancer cell proliferation by enhancing IRS-2-AKT signaling. Cancer Res. 2010;70(22):9197\u2013206.","journal-title":"Cancer Res"},{"key":"1677_CR92","doi-asserted-by":"publisher","first-page":"111070","DOI":"10.1016\/j.mce.2020.111070","volume":"520","author":"Y Hu","year":"2021","unstructured":"Hu Y, et al. High uric acid promotes dysfunction in pancreatic \u03b2 cells by blocking IRS2\/AKT signalling. Mol Cell Endocrinol. 2021;520:111070.","journal-title":"Mol Cell Endocrinol"},{"key":"1677_CR93","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.mce.2016.12.025","volume":"443","author":"H Yuan","year":"2017","unstructured":"Yuan H, et al. Metformin ameliorates high uric acid-induced insulin resistance in skeletal muscle cells. Mol Cell Endocrinol. 2017;443:138\u201345.","journal-title":"Mol Cell Endocrinol"},{"issue":"4","key":"1677_CR94","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.2337\/db10-0916","volume":"60","author":"W Baldwin","year":"2011","unstructured":"Baldwin W, et al. Hyperuricemia as a mediator of the proinflammatory endocrine imbalance in the adipose tissue in a murine model of the metabolic syndrome. Diabetes. 2011;60(4):1258\u201369.","journal-title":"Diabetes"},{"key":"1677_CR95","doi-asserted-by":"publisher","first-page":"653819","DOI":"10.3389\/fendo.2021.653819","volume":"12","author":"C Liu","year":"2021","unstructured":"Liu C, et al. RBP4 is associated with insulin resistance in hyperuricemia-induced rats and patients with hyperuricemia. Front Endocrinol (Lausanne). 2021;12:653819.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1677_CR96","doi-asserted-by":"publisher","first-page":"111599","DOI":"10.1016\/j.mce.2022.111599","volume":"547","author":"F He","year":"2022","unstructured":"He F, et al. Autophagy protects against high uric acid-induced hepatic insulin resistance. Mol Cell Endocrinol. 2022;547:111599.","journal-title":"Mol Cell Endocrinol"},{"issue":"4","key":"1677_CR97","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1016\/j.jhep.2015.11.022","volume":"64","author":"X Wan","year":"2016","unstructured":"Wan X, et al. Uric acid regulates hepatic steatosis and insulin resistance through the NLRP3 inflammasome-dependent mechanism. J Hepatol. 2016;64(4):925\u201332.","journal-title":"J Hepatol"},{"issue":"14","key":"1677_CR98","doi-asserted-by":"publisher","first-page":"6733","DOI":"10.1111\/jcmm.16677","volume":"25","author":"Z Jiao","year":"2021","unstructured":"Jiao Z, et al. Metformin protects against insulin resistance induced by high uric acid in cardiomyocytes via AMPK signalling pathways in vitro and in vivo. J Cell Mol Med. 2021;25(14):6733\u201345.","journal-title":"J Cell Mol Med"},{"issue":"7","key":"1677_CR99","doi-asserted-by":"publisher","first-page":"3197","DOI":"10.1096\/fj.13-247148","volume":"28","author":"YJ Choi","year":"2014","unstructured":"Choi YJ, et al. Uric acid induces endothelial dysfunction by vascular insulin resistance associated with the impairment of nitric oxide synthesis. Faseb j. 2014;28(7):3197\u2013204.","journal-title":"Faseb j"},{"key":"1677_CR100","doi-asserted-by":"publisher","first-page":"98","DOI":"10.3389\/fendo.2018.00098","volume":"9","author":"EJ Tassone","year":"2018","unstructured":"Tassone EJ, et al. Uric acid impairs insulin signaling by promoting Enpp1 binding to insulin receptor in human umbilical vein endothelial cells. Front Endocrinol (Lausanne). 2018;9:98.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"2","key":"1677_CR101","doi-asserted-by":"publisher","first-page":"555","DOI":"10.3390\/ijms22020555","volume":"22","author":"J Cao","year":"2021","unstructured":"Cao J, Yee D. Disrupting insulin and IGF receptor function in cancer. Int J Mol Sci. 2021;22(2):555.","journal-title":"Int J Mol Sci"},{"issue":"5","key":"1677_CR102","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1016\/j.dsx.2018.04.009","volume":"12","author":"B Fathi Dizaji","year":"2018","unstructured":"Fathi Dizaji B. The investigations of genetic determinants of the metabolic syndrome. Diabetes Metab Syndr. 2018;12(5):783\u20139.","journal-title":"Diabetes Metab Syndr"},{"issue":"10","key":"1677_CR103","doi-asserted-by":"publisher","first-page":"e0186296","DOI":"10.1371\/journal.pone.0186296","volume":"12","author":"SY Jung","year":"2017","unstructured":"Jung SY, et al. Genetic variants and traits related to insulin-like growth factor-I and insulin resistance and their interaction with lifestyles on postmenopausal colorectal cancer risk. PLoS ONE. 2017;12(10):e0186296.","journal-title":"PLoS ONE"},{"issue":"5","key":"1677_CR104","doi-asserted-by":"publisher","first-page":"3278","DOI":"10.1128\/MCB.19.5.3278","volume":"19","author":"F Frasca","year":"1999","unstructured":"Frasca F, et al. Insulin receptor isoform A, a newly recognized, high-affinity insulin-like growth factor II receptor in fetal and cancer cells. Mol Cell Biol. 1999;19(5):3278\u201388.","journal-title":"Mol Cell Biol"},{"issue":"10","key":"1677_CR105","doi-asserted-by":"publisher","first-page":"2502","DOI":"10.1210\/me.2004-0183","volume":"18","author":"A Denley","year":"2004","unstructured":"Denley A, et al. Structural determinants for high-affinity binding of insulin-like growth factor II to insulin receptor (IR)-A, the exon 11 minus isoform of the IR. Mol Endocrinol. 2004;18(10):2502\u201312.","journal-title":"Mol Endocrinol"},{"key":"1677_CR106","doi-asserted-by":"publisher","first-page":"789174","DOI":"10.1155\/2012\/789174","volume":"2012","author":"B Arcidiacono","year":"2012","unstructured":"Arcidiacono B, et al. Insulin resistance and cancer risk: an overview of the pathogenetic mechanisms. Exp Diabetes Res. 2012;2012:789174.","journal-title":"Exp Diabetes Res"},{"issue":"12","key":"1677_CR107","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1016\/j.numecd.2014.06.012","volume":"24","author":"G Sesti","year":"2014","unstructured":"Sesti G, et al. Low circulating insulin-like growth factor-1 levels are associated with high serum uric acid in nondiabetic adult subjects. Nutr Metab Cardiovasc Dis. 2014;24(12):1365\u201372.","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"2","key":"1677_CR108","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1007\/s11926-013-0396-1","volume":"16","author":"ML Fernandez","year":"2014","unstructured":"Fernandez ML, Upton Z, Shooter GK. Uric acid and xanthine oxidoreductase in wound healing. Curr Rheumatol Rep. 2014;16(2):396.","journal-title":"Curr Rheumatol Rep"},{"issue":"1","key":"1677_CR109","doi-asserted-by":"publisher","first-page":"641","DOI":"10.3390\/ijms24010641","volume":"24","author":"AM Soliman","year":"2022","unstructured":"Soliman AM, Barreda DR. Acute inflammation in tissue healing. Int J Mol Sci. 2022;24(1):641.","journal-title":"Int J Mol Sci"},{"issue":"4","key":"1677_CR110","doi-asserted-by":"publisher","first-page":"e291","DOI":"10.1002\/mco2.291","volume":"4","author":"Y Jin","year":"2023","unstructured":"Jin Y, et al. Application of stem cells in regeneration medicine. MedComm. 2023;4(4):e291.","journal-title":"MedComm"},{"issue":"18","key":"1677_CR111","doi-asserted-by":"publisher","first-page":"e99911","DOI":"10.1172\/jci.insight.99911","volume":"3","author":"DS Foster","year":"2018","unstructured":"Foster DS, et al. The evolving relationship of wound healing and tumor stroma. JCI Insight. 2018;3(18):e99911.","journal-title":"JCI Insight"},{"issue":"16","key":"1677_CR112","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1177\/15353702211005390","volume":"246","author":"W Yin","year":"2021","unstructured":"Yin W, et al. Cancer and stem cells. Exp Biol Med (Maywood). 2021;246(16):1791\u2013801.","journal-title":"Exp Biol Med (Maywood)"},{"key":"1677_CR113","doi-asserted-by":"publisher","first-page":"174270","DOI":"10.1016\/j.ejphar.2021.174270","volume":"906","author":"H Li","year":"2021","unstructured":"Li H, et al. Xanthine oxidoreductase promotes the progression of colitis-associated colorectal cancer by causing DNA damage and mediating macrophage M1 polarization. Eur J Pharmacol. 2021;906:174270.","journal-title":"Eur J Pharmacol"},{"key":"1677_CR114","doi-asserted-by":"publisher","first-page":"134832","DOI":"10.1016\/j.ijbiomac.2024.134832","volume":"278","author":"Z Ullah","year":"2024","unstructured":"Ullah Z, et al. A comprehensive review on recent xanthine oxidase inhibitors of dietary based bioactive substances for the treatment of hyperuricemia and gout: Molecular mechanisms and perspective. Int J Biol Macromol. 2024;278:134832.","journal-title":"Int J Biol Macromol"},{"key":"1677_CR115","doi-asserted-by":"crossref","unstructured":"Sun Z et al. Recent Progress and Future Perspectives on Anti-Hyperuricemic Agents. J Med Chem. 2024.","DOI":"10.1021\/acs.jmedchem.4c01260"},{"issue":"5","key":"1677_CR116","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1002\/cncr.11612","volume":"98","author":"A Bosly","year":"2003","unstructured":"Bosly A, et al. Rasburicase (recombinant urate oxidase) for the management of hyperuricemia in patients with cancer: report of an international compassionate use study.\u00a0Cancer Interdiscip Int J Am Cancer Soc.\u00a02003;98(5):1048\u201354.","journal-title":"Cancer"},{"issue":"6","key":"1677_CR117","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1016\/j.jbspin.2018.01.008","volume":"85","author":"HC Yang","year":"2018","unstructured":"Yang HC, et al. Gout drugs use and risk of cancer: A case-control study. Joint Bone Spine. 2018;85(6):747\u201353.","journal-title":"Joint Bone Spine"},{"issue":"3","key":"1677_CR118","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1053\/j.ajkd.2017.01.055","volume":"70","author":"AB Vargas-Santos","year":"2017","unstructured":"Vargas-Santos AB, Neogi T. Management of Gout and Hyperuricemia in CKD. Am J Kidney Dis. 2017;70(3):422\u201339.","journal-title":"Am J Kidney Dis"},{"key":"1677_CR119","doi-asserted-by":"crossref","unstructured":"Xue X et al. Associations between serum uric acid and breast cancer incidence: A systematic review and meta-analysis. Am J Med Sci. 2024.","DOI":"10.1016\/j.amjms.2024.07.005"},{"issue":"13","key":"1677_CR120","doi-asserted-by":"publisher","first-page":"7103","DOI":"10.3390\/ijerph18137103","volume":"18","author":"JH Huang","year":"2021","unstructured":"Huang JH, et al. Gender difference in the relationships between inflammatory markers, serum uric acid and framingham risk score. Int J Environ Res Public Health. 2021;18(13):7103.","journal-title":"Int J Environ Res Public Health"},{"issue":"3","key":"1677_CR121","doi-asserted-by":"publisher","first-page":"254","DOI":"10.5551\/jat.39685","volume":"25","author":"H Liu","year":"2018","unstructured":"Liu H, et al. Relationship between Serum Uric Acid and Vascular Function and Structure Markers and Gender Difference in a Real-World Population of China-From Beijing Vascular Disease Patients Evaluation Study (BEST) Study. J Atheroscler Thromb. 2018;25(3):254\u201361.","journal-title":"J Atheroscler Thromb"},{"issue":"7","key":"1677_CR122","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1136\/ard.2009.109884","volume":"69","author":"HA Elisabeth","year":"2010","unstructured":"Elisabeth HA, et al. Menopause, postmenopausal hormone use and risk of incident gout. Ann Rheum Dis. 2010;69(7):1305.","journal-title":"Ann Rheum Dis"},{"issue":"9179","key":"1677_CR123","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1016\/S0140-6736(99)92381-4","volume":"354","author":"H Sumino","year":"1999","unstructured":"Sumino H, et al. Reduction of serum uric acid by hormone replacement therapy in postmenopausal women with hyperuricaemia. Lancet. 1999;354(9179):650.","journal-title":"Lancet"},{"issue":"1","key":"1677_CR124","first-page":"25","volume":"8","author":"A Posadzy-Ma\u0142aczy\u0144ska","year":"2004","unstructured":"Posadzy-Ma\u0142aczy\u0144ska A, et al. Effect of hormone replacement therapy on renal excretion of uric acid and prevalence of thiazide induced hyperuricemia in postmenopausal hypertensive women. Nadcisnienie Tetnicze. 2004;8(1):25\u201332.","journal-title":"Nadcisnienie Tetnicze"},{"issue":"6","key":"1677_CR125","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1089\/152308603770380007","volume":"5","author":"R Budhiraja","year":"2003","unstructured":"Budhiraja R, et al. Estrogen modulates xanthine dehydrogenase\/xanthine oxidase activity by a receptor-independent mechanism. Antioxid Redox Signal. 2003;5(6):705\u201311.","journal-title":"Antioxid Redox Signal"},{"issue":"12","key":"1677_CR126","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1507\/endocrj.EJ13-0203","volume":"60","author":"H Kurahashi","year":"2013","unstructured":"Kurahashi H, et al. Testosterone replacement elevates the serum uric acid levels in patients with female to male gender identity disorder. Endocr J. 2013;60(12):1321\u20137.","journal-title":"Endocr J"},{"issue":"1","key":"1677_CR127","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1111\/j.1447-0594.2009.00552.x","volume":"10","author":"S Fukai","year":"2010","unstructured":"Fukai S, et al. Age-related changes in plasma androgen levels and their association with cardiovascular risk factors in male Japanese office workers. Geriatr Gerontol Int. 2010;10(1):32\u20139.","journal-title":"Geriatr Gerontol Int"},{"key":"1677_CR128","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.jnutbio.2018.08.018","volume":"62","author":"TO Usman","year":"2018","unstructured":"Usman TO, et al. Sodium acetate and androgen receptor blockade improve gestational androgen excess-induced deteriorated glucose homeostasis and antioxidant defenses in rats: roles of adenosine deaminase and xanthine oxidase activities. J Nutr Biochem. 2018;62:65\u201375.","journal-title":"J Nutr Biochem"},{"issue":"7","key":"1677_CR129","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1002\/art.40472","volume":"70","author":"SK Cho","year":"2018","unstructured":"Cho SK, et al. U-Shaped Association Between Serum Uric Acid Level and Risk of Mortality: A Cohort Study. Arthritis Rheumatol. 2018;70(7):1122\u201332.","journal-title":"Arthritis Rheumatol"}],"container-title":["Current Oncology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11912-025-01677-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11912-025-01677-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11912-025-01677-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T03:03:30Z","timestamp":1751598210000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11912-025-01677-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,26]]},"references-count":129,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,6]]}},"alternative-id":["1677"],"URL":"https:\/\/doi.org\/10.1007\/s11912-025-01677-z","relation":{},"ISSN":["1534-6269"],"issn-type":[{"value":"1534-6269","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,26]]},"assertion":[{"value":"9 April 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 April 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All reported studies with human subjects performed by the authors have been previously published and complied with all applicable ethical standards (including the Helsinki declaration and its amendments, institutional\/national research committee standards, and international\/national\/institutional guidelines).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}]}}